Tag Archive for: The Conference Forum

Patients as Partners Conference

We are pleased to announce that we will be attending our parter, The Conference Forum’s, Patients as Partners US Conference this March in Philadelphia, PA. We are looking forward to hearing from leaders in the industry, meeting with colleges, and learning how to incorporate the patient perspective.

The 4th Annual Patients as Partners US is the only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical trial process. It is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum. Join us and  get 15% off using our discount code PEN15 >> http://theconferenceforum.org/conferences/patients-as-partners/overview/. We hope to see you there!

If you cannot attend, please follow along as we will be live tweeting this exciting event! (@power4patients) Tweet us and let us know what you are interested in hearing or learning about!

Register using our coupon code PEN15 for 15% off!

Patients as Partners Event History

When this question was asked to our Disrupting Clinical Trials (DPharm) audience seven years ago, no one raised their hand. Immediately we saw the need for a conference on service for patients in clinical trials. However, more importantly, we saw the urgent need for the patient perspective in driving a conference on collaborating in clinical research.

What Patient Research Taught Us

Patients taught us empathy not only with their disease, but with their lifestyle and struggles in finding and experiencing a clinical trial. In particular, we learned the need to:

  1. Understand and incorporate the patient’s voice in designing clinical trials and developing a clinical endpoint.
  2. Vastly improve the patient’s entire experience in a clinical trial.

If it were not for patient research, we would not have an event 100% designed for the benefit of the patient.

We look forward to seeing you at the 4th annual Patients as Partners US this March 2-3.

Register using our coupon code PEN15 for 15% off!

Patients in Clinical Trials or Patient Advocates Needing Scholarships,
Contact Us at service@tcfllc.org

Accredited by 

#Patients2017 organized by:

Please do not reply directly to this email. Contact onalee@tcfllc.org with any inquiries.

Event overview: http://theconferenceforum.org/conferences/patients-as-partners/overview/
Event press release: http://www.prweb.com/releases/2017/01/prweb14018129.htm
Event hashtag: #Patients2017
TCF Twitter handle: @ConferenceForum

 

Patients as Partners Attendee Julie Walters on Putting the Patient First

Julie Walters discusses the Patients as Partners Event. Blog from our parters at The Conference Forum.

Putting the patient first: Time to stop talking & start doing

It’s rare that you find yourself in the right place, at the right time, with the right people. But it happened last month.

I was part of a small but determined group of people in Philadelphia ready to mount the pharma barricades and, in our view, talk sense.

The event was not just another industry conference. This one was called Patients as Partners and, now in its third year, it meant business.

The pharmaceutical industry doesn’t mean to be inhumane, but sometimes it just is. Regulations have tied good people so much in knots so that the following happens:

  • No outcomes shared from clinical trials, even to those who helped to run the trial. It’s like taking part in a marathon and being told you couldn’t know your finish time
  • No thank you’s to the real people who took the time and considerable energy to take part and try new medicines in development
  • No personal data shared of sometimes invasive procedures like MRIs and X-rays. It’s like your data became someone else’s property at the doctor’s door

It’s nonsense, but how do we change such bad, ingrained habits? Like anything in the world, change takes a small but committed group of people.


As one person put it so simply and clearly:
How would you like your mother to be treated if she took part in a clinical trial?


Someone saying thank you at the end of the process would seem a good start.

Trailblazers are starting to make a difference: patient data delivered in real time to those who took part even while a trial is still ongoing. Yes it is possible! Not easy, but possible. Families affected by a condition in the same room as those developing new treatments so they can learn from each other. The lawyers are not comfortable but again it can be done. It has got to be better than observing patients talking about living with their condition from behind a two-way mirror. Not so much patients as partners; more patients as criminals.

The industry’s behavior is motivated by fear; fear of getting it wrong, fear of going too far, fear of being accused of trying to sell a family a drug years before it’s even been tested (yes really!) and fear of their career coming to an abrupt stop.

I understand how it’s come about but this fear-based approach is no longer fit for purpose in a world that now has the technology to truly share experience and knowledge.

So if your colleague attended #Patients2016, ask how you can help & wish them luck. We’ll need it.

Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has.” Margaret Mead

Tag Archive for: The Conference Forum

Disruptive Innovations US

The Conference Forum was delighted to present the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference, with a full day dedicated to Mobile in Clinical Trials on Wednesday September 6. Mark your calendars, DPharm 2018 will take place, September 25-26 in Boston. We are dedicated to presenting the annual event that the life science industry can rely on for the latest thinking in clinical trials for 21st century drug development.

Clinical Research as a Care Option

Overview

Bring Clinical Research Closer to Patients & Patients Closer to Clinical Trials

Arguably the greatest change we can collaborate on in bringing patients closer to clinical research is to make clinical trials a care option. Higher rates of clinical trial participation inside of a health system produces better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research and pharma can get access to more patients in need of clinical research options.

Clinical research is typically transactional and not integrated as part of a healthcare organization’s care options. Patients almost never learn about clinical research from their physicians unless their physicians are directly engaged in a clinical trials. The value of integrating clinical research into the overall continuum of care is often lost on health care organizations and in this meeting, we address how to bridge the gap and overcome many of the obstacles.

Who Will Benefit From Attending CRAACO

From Pharma, Biotech, CROs:

  • Heads of Clinical Operations, Clinical Innovation
  • Heads of Health Economics/Outcome Research
  • Value & Policy
  • Health Systems
  • CMOs
  • Chief Quality/Outcome Officers
  • Chief Patient Officers, Patient Services and Recruitment

From Hospitals/Health Care Organizations, Medical Groups, Physician Groups:

  • Chief Administrators
  • Physician Champions/leads
  • Therapeutic Heads
  • Population Health
  • Head of Clinical Operations

The Following Organizations will also Benefit:

  • Investigative Sites
  • Patient Advocacy Foundations and Trusts
  • Patient Recruitment Services
  • IT and Health Care Consultants and Technology Firms
  • Medical Informatics

Clinical Trial Collaborations

Overview

The Clinical Trial Collaborations (CTC) conference is a strategic level event focusing on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes.

We are pleased to announce that the 3rd annual conference is co-chaired by Ken GetzDirector of Sponsored Research ProgramsTufts CSDD and Murray Abramson, MDVP Global Clinical OperationsBiogen. Ken also gives the state of the industry address on Mapping the Evolution of Contract Clinical Collaborations to help prepare operation professionals with an understanding of the latest data on:

  1. The strategic implications of an unprecedented level of acquisitions dominated by private equity investment
  2. The current structure and concentration of the CRO marketplace
  3. What to think about and how to prepare for the changing clinical outsourcing landscape

– CTC is Divided into Three Sections –

  1. Clinical Collaborations: The Evolution, Current Examples to Challenge Us & Progress
  2. Strategic Collaborations, Virtual Trials & Next Generation Monitoring
  3. Clinical Research as a Care Option & How to Collaborate to Achieve This

– 2018 Highlights –

Clinical Operation Veteran Leadership

Jay KaminskiSVP, Global Clinical R&D OperationsCelgene provides a bold and fresh approach to creating a collaborative ecosystem for a 12 month clinical trial!

Industry veteran, Dr Jeremy ChadwickGroup VP, Clinical Development Operations, Shire Pharmaceuticals, joins conference chair, Dr Murray Abramson in a fireside chat. Together, they address what it takes to develop strategic relationships between sponsors and vendors that deliver results and they will give the audience an opportunity to do Q&A with them.

Transformative Collaborations in Clinical Trials

Back by popular demand! We are delighted to confirm that Azmi Nabulsi, MDDeputy Chief Medical & Scientific Officer, Head of R&D Strategic & Professional AffairsTakeda together with Tami KlerrEVP Global Business DevelopmentPRA Health Sciences, talk about how their transformative collaboration is doing a year later. What are the lessons learned that we can benefit from?

Michelle ShogrenPortfolio and Operations Innovation Manager, Bayer and Joseph Kim, MBASenior Advisor Clinical InnovationEli Lilly share their journeys co-collaborating with startups to create pathways and achieve deliverables more effectively. They explore the potential of innovative startups within the clinical development process while managing the inherent risk of stepping outside of traditional lines.

Collaborating Towards Virtual Trials

Dr Tomasz SablinskiFounderTransparency Life Sciences, and Komathi Stem, MS,FoundermonARC Bionetworks, are some of the most disruptive thinkers and doers as they forge ahead in the development of clinical partnerships to make trials more virtual for the benefit of the patients. They will be joined by their sponsor partners in co-presentations to help us understand how to collaborate for virtual/semi-virtual clinical trials. They will also be joined by Science 37’s, Marcella DebiddaVP Patient Engagement.

Collaborating for Compliance

EMD Serono discusses their key strategic partnerships with regulatory agencies and patient associations to take on a high-risk, modern, and efficient late stage clinical trial. How did this approach benefit them on the road to eventual drug approval?

Hear how Ann HegartyExecutive Director GSMO, CRO OversightAllergan and their CRO partner are navigating FDA guidance ICH E6 (R2) together using a strategic approach to make their collaboration compliant and effective.

April 11th
2nd Annual Clinical Research as a Care Option (CRAACO)

Since 2015, we’ve presented the topic of Clinical Research as a Care Option. Thanks to Katherine VandebeltChief Ecosystem Officer, Reify HealthJennifer ByrneFounder,The Greater GiftJeff JamesCEO, Wilmington Health and Jane Shen, PharmDPresident of the Board of Directors at Wake Forest Healthcare Venture who first presented this topic on the DPharm stage, we are delighted to build on their experience and bring this full day agenda on April 11th.

The movement of integrating clinical research into medical care requires the entire healthcare and clinical research ecosystems to collaborate and advocate for change. Why are clinical trials not typically a care option? How do we create physician champions? These are just a few of the topics at CRAACO we are excited to address with a top notch speaking faculty.

Patients as Partners US

The 5th annual Patients as Partners program is the only conference in the US that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.

Featured Speakers

Ken Getz, MBA
Tufts CSDD, CISCRP
Roslyn Schneider, MD
Pfizer
Mary Stober Murray
Bristol-Myers Squibb
Beth Zaharoff
Tesaro
Marc Boutin, JD
National Health Council
Geraldine Blavat
Patient and Advocate
Stefanie Joho
Survivor and Advocate
Meyer Carol colorCarol Meyer
Takeda

– Overview –

Patients as Partners is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum.

  1. Patients as Partners US is accredited by Patients Included and addresses what matters most to patients to enable them to support clinicalresearch:
    1. Understanding and incorporating the patient’s voice in designing clinical trials and developing a clinical endpoint
    2. Vastly improving the patient’s entire experience in a clinical trial
    3. Empowering the patient in the new medicines development process
  2.  We are pleased to bring back “Ask the Patient” to Patients as Partners US, a program representing a group of individuals who’ve experienced a clinical trial.These patients, our Medical Heroes, will be available to answer questions about their clinical trial experience. It is a great opportunity to learn about the realities of a clinical trial directly from the patient’s point of view. They will have a badge identifying their participation and will be available throughout the conference. We will also have an area in the exhibit hall to meet them during breaks.
  3. The conference room will be set up in rounds for easier interaction and each table will be provided with a paper “Tool-Box” and an assortment of specially designed materials to help capture ideas.
    • Each session will conclude with a list of key take-aways presented from the session representative.
    • Result: Each attendee will walk away with a toolbox full of ideas that will support their patient involvement initiatives.

Turning  Discussion Into Action

Dr Theresa Mullin, FDA, delivered a progress report on PDUFA VI and an update on the new performance and procedural goal at the 2017 conference.

Ken Getz, Tufts CSDD, CISCRP, delivered a presentation on raising awareness in clinical research at the 2017 conference.

Marilyn Metcalf, GSK, led a patient and researcher panel on the medicine information exchange at the 2017 conference.

A multi-stakeholder panel addressing patient and industry needs in medicines development.
From left to right: Ken Getz, Tufts, CISCRP, T.J. Sharpe, Patient and Advocate, Durhane Wong-Reiger, PhD, Canadian Organization for Rare Disorders, Jean McCoy, Health Advocacy Strategies, Janet Freeman-Daily, Lung Cancer Patient and Activist, Marilyn Metcalf, GSK

 

A special thanks to our advisors for their unwavering guidance and expertise in helping us with the research to craft an in-depth agenda that puts the “discussion” around patient involvement into action across the entire clinical development continuum.

We look forward to seeing you in Philadelphia, March 15-16, 2018.

Sincerely,

 kate-bw-3Kate Woda
Conference Director
Valerie Bowling New 

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Business Development 
Manager
 

Kim Chin
Marketing Director

 elizabeth-bard-bw-2Elizabeth Bard
Business Development Manager
 jackiedt-bwJackie Della Torre
Business Development Manager
Nancy-BW-2 

Nancy Belis
Senior Conference Planner

Laura Mulchay 

Laura Mulchay 
Marketing Associate

Immuno-Oncology 360°

The Conference Forum is hosting an Immuno-Oncology 360°, which is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:

  • Discovery / Preclinical Science

  • Translational Science

  • Clinical Development

  • Business Aspects

  • Investor Relations

  • Emerging Technologies

  • Biomarkers / Diagnostics

  • Trends in the Field

2018 IO360 main speakers

Overview

Dr Axel HoosGSK and Dr James GulleyNCI, together led the design of the 4th annual Immuno-Oncology 360° program to include 45 speakers and over 30 talks. We are delighted to announce that Dr Andrew Baum  is confirmed as the investor relations plenary keynote.

Featured Speakers

IO360 Featured Speakers

Immuno-Oncology 360° provides the most up-to-date research, data and progress to help IO stakeholders:

  • Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
  • Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof​
  • Receive the latest pre-clinical, translational and clinical data from academic and industry
  • Identify and gain a greater understanding of what assets are available for potential combinations  
  • Create and prioritize strategies targeted toward specific tumor types​
  • Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
  • Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
  • Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot
  • Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
  • Obtain coverage on a wide range of emerging technologies

Click Here To Register

Press Release

About The Conference Forum

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

The Conference Forum presents strategic level conferences, both public and private, as well as developing focus groups and advisory boards for professionals in the life science and healthcare industries. They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.

To suggest new topic areas or educational formats you would like to see us cover, please email Customer Service or call 646-350-2580.